AmerisourceBergen Corporation (ABC) Q4 2022 Earnings Call Transcript
Prepared Remarks
Questions and Answers
Call Participants
Prepared Remarks:
Operator
Ladies and gentlemen, welcome to the AmerisourceBergen Q4 FY 2022 Earnings Call. My name is Glenn, and I will be coordinating your call today. I'll now hand you over to your host, Bennett Murphy, to begin. Please go ahead.
Bennett Murphy - SVP, IR
Thank you. Good morning, good afternoon, and thank you all for joining us for this conference call to discuss AmerisourceBergen's fiscal 2022 fourth quarter and full year results. I am Bennett Murphy, Senior Vice President, Investor Relations. Joining me today are Steve Collis, Chairman, President and CEO; and Jim Cleary, Executive Vice President and CFO.
On today's call, we'll be discussing non-GAAP financial measures. Reconciliations of these measures to GAAP are provided in today's press release, which is available on our Web site at investor.amerisourcebergen.com. We have posted a slide presentation to accompany today's press release on our investor website.
During this conference call, we will make forward-looking statements about our business and financial expectations on an adjusted non-GAAP basis, including, but not limited to, EPS, operating income and income taxes. Forward-looking statements are based on management's current expectations and are subject to uncertainty and change. For a discussion of key risks and assumptions, we refer you to today's press release and our SEC filings, including our most recent 10-K. AmerisourceBergen assumes no obligation to update any forward-looking statements, and this call cannot be or broadcast without the express permission of the company. You will have an opportunity to ask questions after today’s remarks by management. We ask you that you limit your questions to one per participant in order for us to get to as many participants as possible in the hour.
With that, I'll turn the call over to Steve.
Steven Collis - Chairman, President & CEO
Thank you, Bennett. Good morning and good afternoon to everyone on the call. Today my remarks will focus on the successes of our 2022 fiscal year and the ways in which our leading distribution and pharmaceutical solution capabilities are core to advancing global pharmaceutical innovation and access, ultimately driving significant value creation for all our stakeholders.
AmerisourceBergen delivered another strong fiscal year, driven by the resilience and strength of our business, as our team continue to execute to advance our strategic priorities, and build on our foundation for future growth. First, we leverage the strength of our leading pharmaceutical distribution businesses.